JP2011190199A5 - - Google Patents

Download PDF

Info

Publication number
JP2011190199A5
JP2011190199A5 JP2010056428A JP2010056428A JP2011190199A5 JP 2011190199 A5 JP2011190199 A5 JP 2011190199A5 JP 2010056428 A JP2010056428 A JP 2010056428A JP 2010056428 A JP2010056428 A JP 2010056428A JP 2011190199 A5 JP2011190199 A5 JP 2011190199A5
Authority
JP
Japan
Prior art keywords
rheumatoid arthritis
administration
administered
bed
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010056428A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011190199A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2010056428A priority Critical patent/JP2011190199A/ja
Priority claimed from JP2010056428A external-priority patent/JP2011190199A/ja
Priority to PCT/JP2010/007262 priority patent/WO2011111143A1/ja
Publication of JP2011190199A publication Critical patent/JP2011190199A/ja
Publication of JP2011190199A5 publication Critical patent/JP2011190199A5/ja
Pending legal-status Critical Current

Links

JP2010056428A 2010-03-12 2010-03-12 関節リウマチ薬 Pending JP2011190199A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2010056428A JP2011190199A (ja) 2010-03-12 2010-03-12 関節リウマチ薬
PCT/JP2010/007262 WO2011111143A1 (ja) 2010-03-12 2010-12-15 関節リウマチ薬

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010056428A JP2011190199A (ja) 2010-03-12 2010-03-12 関節リウマチ薬

Publications (2)

Publication Number Publication Date
JP2011190199A JP2011190199A (ja) 2011-09-29
JP2011190199A5 true JP2011190199A5 (cg-RX-API-DMAC10.html) 2013-04-25

Family

ID=44562991

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010056428A Pending JP2011190199A (ja) 2010-03-12 2010-03-12 関節リウマチ薬

Country Status (2)

Country Link
JP (1) JP2011190199A (cg-RX-API-DMAC10.html)
WO (1) WO2011111143A1 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180134997A1 (en) 2015-06-09 2018-05-17 Danisco Us Inc. Osmotic burst encapsulates
WO2016201069A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc Low-density enzyme-containing particles
WO2016201040A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc. Water-triggered enzyme suspension
EP3601515A1 (en) 2017-03-31 2020-02-05 Danisco US Inc. Delayed release enzyme formulations for bleach-containing detergents
WO2019006077A1 (en) 2017-06-30 2019-01-03 Danisco Us Inc PARTICLES CONTAINING LOW AGGLOMERATION ENZYME
CN111742041B (zh) 2017-12-21 2023-06-06 丹尼斯科美国公司 包含耐热干燥剂的含酶的热熔细粒
BR112020016068A2 (pt) 2018-02-08 2020-12-08 Danisco Us Inc. Partículas cera termicamente resistente matriz para encapsulamento de enzima
EP3844255A1 (en) 2018-08-30 2021-07-07 Danisco US Inc. Enzyme-containing granules
HUE059638T2 (hu) * 2019-05-10 2022-12-28 Synact Pharma Aps Ízületi gyulladásos betegségek kombinált kezelése
IL309102A (en) 2021-06-21 2024-02-01 Synact Pharma Aps Salts and formulations of phenyl pyrrole aminoguanidine
WO2023039270A2 (en) 2021-09-13 2023-03-16 Danisco Us Inc. Bioactive-containing granules

Similar Documents

Publication Publication Date Title
JP2015057451A5 (cg-RX-API-DMAC10.html)
JP2010503695A5 (cg-RX-API-DMAC10.html)
JP2013541583A5 (cg-RX-API-DMAC10.html)
JP2015523407A5 (cg-RX-API-DMAC10.html)
JP2017506624A5 (cg-RX-API-DMAC10.html)
HK1221646A1 (zh) 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途
JP2016147915A5 (cg-RX-API-DMAC10.html)
JP2015522630A5 (cg-RX-API-DMAC10.html)
JP2012193216A5 (cg-RX-API-DMAC10.html)
JP2013209384A5 (cg-RX-API-DMAC10.html)
EA201590797A1 (ru) Препараты с модифицированным высвобождением опрозомиба
JP2012505830A5 (cg-RX-API-DMAC10.html)
MX2015009546A (es) Dosificacion aumentada de efavirenz para el tratamiento de cancer.
JP2014058509A5 (cg-RX-API-DMAC10.html)
HRP20161796T1 (hr) Farmaceutski pripravak za primjenu u tretmanu ili prevenciji deficijencije vitamina i minerala kod pacijenata podvrgnutih operaciji želučane premosnice
SA516370446B1 (ar) تركيبة صيدلانية مستقرة مضادة للدرن في صورة قرص قابل للتشتت يحتوي على حبيبات إيزونيازيد وحبيبات ريفابنتين، وعملية لتحضيرها
JP2017531042A5 (cg-RX-API-DMAC10.html)
JP2016504361A5 (cg-RX-API-DMAC10.html)
HRP20220701T1 (hr) Spojeni benzazepini za liječenje touretteova sindroma
JP2017511307A5 (cg-RX-API-DMAC10.html)
JP2015509934A5 (cg-RX-API-DMAC10.html)
EA201290378A1 (ru) Композиции, содержащие нестероидные противовоспалительные лекарственные средства
JP2017530142A5 (cg-RX-API-DMAC10.html)
RU2016145411A (ru) Комбинация брекспипразола и налмефена, и ее применение для лечения синдрома химической зависимости
HRP20160811T1 (hr) Upotreba odiparcila u liječenju mukopolisaharidoze